Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

Last updated: February 25, 2025
Sponsor: NYU Langone Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Deafness

Treatment

Electrode-Neural Interface

Clinical Study ID

NCT05810220
18-00323
  • Ages 2-90
  • All Genders

Study Summary

This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlearimplants.

  • No diagnosis of any other communicative or cognitive disorder other than hearingimpairment. The individual must be able to visit the lab in order to participate inbehavioral and electrophysiological experiments.

  • Patients' implant device must have useable electrodes that do not result inuncomfortable or unpleasant non-auditory sensation.

Exclusion

Exclusion Criteria:

  • Diagnosed cognitive or communicative disorders (other than hearing impairment)

  • Severe neurological disorders

  • No useable electrodes in their implants

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Electrode-Neural Interface
Phase:
Study Start date:
December 02, 2018
Estimated Completion Date:
December 30, 2026

Connect with a study center

  • NYU Langone Health

    New York, New York 10016
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.